Targeting SARS-CoV-2 non-structural protein 13 via helicase-inhibitor-repurposing and non-structural protein 16 through pharmacophore-based screening.

Samdani, Md Nazmus; Morshed, Niaz; Reza, Rumman; Asaduzzaman, Muhammad; Islam, Abul Bashar Mir Md Khademul

Samdani, Md Nazmus; Morshed, Niaz; Reza, Rumman; Asaduzzaman, Muhammad; Islam, Abul Bashar Mir Md Khademul.

Afiliação

Samdani MN; Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka, 1000, Bangladesh.
Morshed N; Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka, 1000, Bangladesh.
Reza R; Department of Pharmacy, Faculty of Pharmacy, University of Dhaka, Dhaka, 1000, Bangladesh.
Asaduzzaman M; Department of Clinical Pharmacy and Pharmacology, Faculty of Pharmacy, University of Dhaka, Dhaka, 1000, Bangladesh. asaduzzaman@du.ac.bd.
Islam ABMMK; Department of Genetic Engineering and Biotechnology, University of Dhaka, Dhaka, 1000, Bangladesh. khademul@du.ac.bd.

Mol Divers ; 27(3): 1067-1085, 2023 Jun.

Article em En | MEDLINE | ID: mdl-35690957

Assuntos

COVID-19; Humanos; Reposicionamento de Medicamentos; Farmacóforo; SARS-CoV-2; Ivermectina; Simulação de Dinâmica Molecular; Simulação de Acoplamento Molecular

Palavras-chave

COVID-19; Molecular docking; Molecular dynamics simulations; Non-structural protein 13; Non-structural protein 16; Pharmacophore; SARS-CoV-2; Virtual screening

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: COVID-19 Tipo de estudo: Diagnostic_studies / Screening_studies Limite: Humans Idioma: En Revista: Mol Divers Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Bangladesh País de publicação: Holanda

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google